Sloan Kettering Seeks More Sanctions In Drug IP Case
By Matthew Guarnaccia · February 9, 2017, 3:33 PM EST
The Sloan Kettering Institute again asked a New York federal judge to sanction a biopharmaceutical company and its counsel in a now-dismissed lawsuit over gene therapy patent rights, saying Wednesday the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login